| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ariana P Gatt, Emma L Jones, Paul T Francis, Clive Ballard, Joseph M Batema. Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies. Neuroscience letters. vol 557 Pt B. 2014-08-18. PMID:24184878. |
to test this hypothesis rs2306604 genotype was determined in 141 controls and 135 patients with dementia with lewy bodies (dlb) or parkinson's disease dementia (pdd). |
2014-08-18 |
2023-08-12 |
Not clear |
| Ariana P Gatt, Emma L Jones, Paul T Francis, Clive Ballard, Joseph M Batema. Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies. Neuroscience letters. vol 557 Pt B. 2014-08-18. PMID:24184878. |
therefore, the genetic factors that predispose individuals to develop dementia may differ in pdd and dlb. |
2014-08-18 |
2023-08-12 |
Not clear |
| Carol Sheei-Meei Wang, Ming-Chyi Pai, Pai-Lien Chen, Nien-Tsen Hou, Pei-Fang Chien, Ying-Che Huan. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan. International psychogeriatrics. vol 25. issue 11. 2014-08-13. PMID:23919950. |
the aim of this study was to examine and test the sensitivity, specificity, and threshold scores of the montreal cognitive assessment (moca) and the mini-mental state examination (mmse) and determine those that best correspond to a clinical diagnosis of dementia with lewy bodies (dlb). |
2014-08-13 |
2023-08-12 |
human |
| Adrienne Henderson-Smith, Donald Chow, Bessie Meechoovet, Meraj Aziz, Sandra A Jacobson, Holly A Shill, Marwan N Sabbagh, John N Caviness, Charles H Adler, Erika D Driver-Dunckley, Thomas G Beach, Hongwei Yin, Travis Dunckle. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening. PloS one. vol 8. issue 10. 2014-08-05. PMID:24204929. |
moreover, smg1 protein levels were significantly reduced in brain regions with high p-syn levels in both dementia with lewy bodies (dlb) and parkinson's disease with dementia (pdd). |
2014-08-05 |
2023-08-12 |
human |
| Elisabeth Kapaki, George P Paraskevas, Evangelia Emmanouilidou, Kostas Vekrelli. The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease. PloS one. vol 8. issue 11. 2014-08-05. PMID:24282614. |
the aim of the present study was to determine the diagnostic value of α-syn as a biological marker for dementia with lewy bodies (dlb) vs. normal subjects and patients with alzheimer's disease (ad), after strict control of several recognized confounders. |
2014-08-05 |
2023-08-12 |
human |
| Emma Vardy, Rachel Holt, Alex Gerhard, Anna Richardson, Julie Snowden, David Near. History of a suspected delirium is more common in dementia with Lewy bodies than Alzheimer's disease: a retrospective study. International journal of geriatric psychiatry. vol 29. issue 2. 2014-07-25. PMID:23722989. |
we performed a retrospective study of alzheimer's disease (ad) and dementia with lewy bodies (dlb) to ascertain whether a suspected episode of preceding delirium was more common prior to diagnosis in either type of dementia. |
2014-07-25 |
2023-08-12 |
Not clear |
| John-Paul Taylor, Sean J Colloby, Ian G McKeith, John T O'Brie. Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in dementia with Lewy bodies. International psychogeriatrics. vol 25. issue 12. 2014-07-25. PMID:24148774. |
fluctuating cognition (fc), particularly in attention, is a core and defining symptom in dementia with lewy bodies (dlb) but is seen much less frequently in alzheimer's dementia (ad). |
2014-07-25 |
2023-08-12 |
Not clear |
| Gretchel Ajon Gealog. Dementia with Lewy bodies: a comprehensive review for nurses. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. vol 45. issue 6. 2014-07-17. PMID:24217145. |
there is a paucity of nursing literature on dementia with lewy bodies (dlb), the second most common subtype of dementia, which is closely associated with parkinson disease with dementia (pdd), considered the third most common dementia subtype. |
2014-07-17 |
2023-08-12 |
Not clear |
| Gretchel Ajon Gealog. Dementia with Lewy bodies: a comprehensive review for nurses. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. vol 45. issue 6. 2014-07-17. PMID:24217145. |
dlb is defined as dementia onset that is preceded by parkinsonian symptoms for 1 year or less, whereas in pdd, 2 or more years of parkinsonian symptoms precede dementia onset. |
2014-07-17 |
2023-08-12 |
Not clear |
| Elijah Mak, Li Su, Guy B Williams, John T O'Brie. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimer's research & therapy. vol 6. issue 2. 2014-07-17. PMID:25031634. |
this review summarises the findings and applications from neuroimaging studies in dementia with lewy bodies (dlb), highlighting key differences between dlb and other subtypes of dementia. |
2014-07-17 |
2023-08-13 |
Not clear |
| Elijah Mak, Li Su, Guy B Williams, John T O'Brie. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimer's research & therapy. vol 6. issue 2. 2014-07-17. PMID:25031634. |
dlb shares common clinical, neuropsychological and pathological features with parkinson's disease dementia and other dementia subtypes, such as alzheimer's disease. |
2014-07-17 |
2023-08-13 |
Not clear |
| Elijah Mak, Li Su, Guy B Williams, John T O'Brie. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimer's research & therapy. vol 6. issue 2. 2014-07-17. PMID:25031634. |
the importance of developing accurate imaging markers in dementia is highlighted by the potential for treatments targeting specific molecular abnormalities as well as the responsiveness to cholinesterase inhibitors and marked neuroleptic sensitivity of dlb. |
2014-07-17 |
2023-08-13 |
Not clear |
| Elijah Mak, Li Su, Guy B Williams, John T O'Brie. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimer's research & therapy. vol 6. issue 2. 2014-07-17. PMID:25031634. |
dopamine transporter loss has proven to reliably differentiate dlb from other dementias and has been incorporated into the revised clinical diagnostic criteria for dlb. |
2014-07-17 |
2023-08-13 |
Not clear |
| Jennifer Rose V Molan. Dementia with Lewy bodies. Seminars in neurology. vol 33. issue 4. 2014-07-14. PMID:24234353. |
dementia with lewy bodies (dlb) is a synucleinopathy that is clinically distinct from alzheimer's disease, associated with cognitive decline, fluctuations in alertness and cognition, visual hallucinations, and parkinsonism. |
2014-07-14 |
2023-08-12 |
Not clear |
| Heather McCann, Claire H Stevens, Heidi Cartwright, Glenda M Hallida. α-Synucleinopathy phenotypes. Parkinsonism & related disorders. vol 20 Suppl 1. 2014-07-11. PMID:24262191. |
there are three main types of α-synucleinopathy, parkinson's disease (pd), dementia with lewy bodies (dlb), and multiple system atrophy (msa), with other rare disorders also having α-synuclein pathologies, such as various neuroaxonal dystrophies. |
2014-07-11 |
2023-08-12 |
Not clear |
| Jessica Rodrigues Brazète, Jacques Montplaisir, Dominique Petit, Ronald B Postuma, Josie-Anne Bertrand, Daphné Génier Marchand, Jean-François Gagno. Electroencephalogram slowing in rapid eye movement sleep behavior disorder is associated with mild cognitive impairment. Sleep medicine. vol 14. issue 11. 2014-07-08. PMID:24095264. |
idiopathic rapid eye movement (rem) sleep behavior disorder (irbd) is a well-documented risk factor for synucleinopathies such as parkinson disease (pd) and dementia with lewy bodies (dlb). |
2014-07-08 |
2023-08-12 |
Not clear |
| Iddo Magen, Marie-Françoise Chessele. Mouse models of cognitive deficits due to alpha-synuclein pathology. Journal of Parkinson's disease. vol 1. issue 3. 2014-07-07. PMID:23939303. |
they include parkinson's disease (pd) and dementia with lewy bodies (dlb), which are both linked to cognitive decline. |
2014-07-07 |
2023-08-12 |
mouse |
| Iddo Magen, Marie-Françoise Chessele. Mouse models of cognitive deficits due to alpha-synuclein pathology. Journal of Parkinson's disease. vol 1. issue 3. 2014-07-07. PMID:23939303. |
in dlb, dementia dominates the symptoms whereas in pd, subtle cognitive deficits are frequent and may appear even before motor symptoms, but only a fraction of patients develop severe dementia-type cognitive deficits. |
2014-07-07 |
2023-08-12 |
mouse |
| Giacomo Rolma, Nela Jelcic, Francesca Gnoato, Diego Cecchin, Annachiara Cagni. Combined duloxetine and benzodiazepine-induced visual hallucinations in prodromal dementia with Lewy bodies. General hospital psychiatry. vol 35. issue 6. 2014-07-03. PMID:23523020. |
we describe a patient with prodromal dementia with lewy bodies (dlb) presenting with drug-induced visual hallucinations (vhs). |
2014-07-03 |
2023-08-12 |
Not clear |
| Oskar Hansson, Sara Hall, Annika Ohrfelt, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Katarina Nägga, Elisabet Londos, Shiji Varghese, Nour K Majbour, Abdulmonem Al-Hayani, Omar Ma El-Agna. Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease. Alzheimer's research & therapy. vol 6. issue 3. 2014-07-02. PMID:24987465. |
the objective was to study whether α-synuclein oligomers are altered in the cerebrospinal fluid (csf) of patients with dementia, including parkinson disease with dementia (pdd), dementia with lewy bodies (dlb), and alzheimer disease (ad), compared with age-matched controls. |
2014-07-02 |
2023-08-13 |
Not clear |